8102
-
Biologics: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Biologics: Targets and Therapy
(1,101,174) Views
Editor in Chief Dr Doris Mangiaracina Benbrook
1177-5475
Gefitinib and high-dose fractionated radiotherapy for carcinomatous encephalitis from non-small cell lung carcinoma
Eric T Wong, Julian K Wu, Anand Mahadevan
Biologics: Targets and Therapy 2007, 1:321-324
21 January 2007
Ultrasound assessment of salivary glands in patients with primary Sjögren's syndrome treated with rituximab: Quantitative and Doppler waveform analysis
Sandrine Jousse-Joulin, Valérie Devauchelle-Pensec, Johanne Morvan, Bruno Guias, Yvon Pennec, et al
Biologics: Targets and Therapy 2007, 1:311-319
21 January 2007
Efalizumab in the treatment of psoriasis
Wolf-Henning Boehncke
Biologics: Targets and Therapy 2007, 1:301-309
21 January 2007
Agalsidase alfa (Replagal™) in the treatment of Anderson-Fabry disease
Gregory M Pastores
Biologics: Targets and Therapy 2007, 1:291-300
21 January 2007
The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complex
Massimo Franchini, Giuseppe Lippi
Biologics: Targets and Therapy 2007, 1:285-289
21 January 2007
A review of antisense therapeutic interventions for molecular biological targets in asthma
Florin-Dan Popescu, Florica Popescu
Biologics: Targets and Therapy 2007, 1:271-283
21 January 2007
Nonsurgical treatment of male infertility: specific and empiric therapy
Marcello Cocuzza, Ashok Agarwal
Biologics: Targets and Therapy 2007, 1:259-269
21 January 2007
The molecular genetics of breast cancer and targeted therapy
Rachel Suter, James A Marcum
Biologics: Targets and Therapy 2007, 1:241-258
21 January 2007
Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer
Elizabeth S Henson, James B Johnston, Marek Los, Spencer B Gibson
Biologics: Targets and Therapy 2007, 1:229-239
21 January 2007
90Yttrium ibritumomab tiuxetan in the treatment of non-Hodgkin's lymphoma: current status and future prospects
Samuel A Jacobs
Biologics: Targets and Therapy 2007, 1:215-227
30 April 2007
The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept
Renaud Snanoudj, Carlos Frangié, Benjamin Deroure, Hélène François, Caroline Créput, et al
Biologics: Targets and Therapy 2007, 1:203-213
21 January 2007
A review of treatment of Pompe disease in infants
Yin-Hsiu Chien, Wuh-Liang Hwu
Biologics: Targets and Therapy 2007, 1:195-201
21 January 2007
Targeted therapy of advanced non-small cell lung cancer: the role of bevacizumab
Thomas E Stinchcombe
Biologics: Targets and Therapy 2007, 1:185-194
21 January 2007
Editorial: On the diversity of biological therapeutics ||Free Paper||
Sanjay Awasthi
Biologics: Targets and Therapy 2007, 1:183-184
21 January 2007
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed
